DSpace@İnönü

Factors effecting platelet activation in children with poorly controlled type 1 diabetes mellşitus

Basit öğe kaydını göster

dc.contributor.author Swartz, Jonathan M.
dc.contributor.author Akıncı, Ayşehan
dc.contributor.author Andrew, Shayne F.
dc.contributor.author Sığırcı, Ahmet
dc.contributor.author Andrew, Shayne F.
dc.contributor.author Hirschhorn, Joel N
dc.contributor.author Rosenfeld, Ron G.
dc.contributor.author Dauber, Andrew
dc.contributor.author Hwa, Vivian
dc.date.accessioned 2017-07-09T13:50:19Z
dc.date.available 2017-07-09T13:50:19Z
dc.date.issued 2013
dc.identifier.citation ASLAN, M., AKINCI, A., DERYA GÜMÜŞ, D., ÜNSAL, O., & KARADAĞ, A. (2013). factors effecting platelet activation in children with poorly controlled type 1 diabetes mellşitus. HealthMED, 7(7), 2227–2234. tr_TR
dc.identifier.issn 1840-2291
dc.identifier.uri http://hdl.handle.net/11616/7346
dc.description HealthMED tr_TR
dc.description.abstract Background—Cockayne syndrome is an autosomal recessive, heterogeneous syndrome with classic features, including short stature, microcephaly, developmental delay, neuropathy, and photosensitivity. New genomic approaches offer improved molecular diagnostic potential. Methods—Whole-exome sequencing was employed to study a consanguineous extended family with severe short stature and variable presentations of peripheral neuropathy, lipoatrophy, photosensitivity, webbed neck, and hirsutism. Results—We identified a novel homozygous ERCC6 variant at the donor splice site of intron 9 (c.1992+3A>G), which was predicted to only slightly perturb splicing efficiencies. Assessment of primary fibroblast-derived mRNAs, however, revealed a dominant splicing species that utilized an unsuspected putative donor splice site within exon 9, resulting in predicted early protein termination (p.Arg637Serfs*34). Conclusions—We describe a new splicing ERCC6 defect causal of Cockayne syndrome. The application of exome sequence analysis was integral to diagnosis, given the complexity of phenotypic presentation in affected family members. The novel splicing defect, furthermore, illustrates how a seemingly minor change in the relative strength of a splice site can have significant biological consequences. tr_TR
dc.language.iso eng tr_TR
dc.publisher HealthMED tr_TR
dc.rights info:eu-repo/semantics/openAccess tr_TR
dc.title Factors effecting platelet activation in children with poorly controlled type 1 diabetes mellşitus tr_TR
dc.type article tr_TR
dc.relation.journal HealthMED tr_TR
dc.contributor.department İnönü Üniversitesi tr_TR
dc.identifier.volume 7 tr_TR
dc.identifier.issue 7 tr_TR
dc.identifier.startpage 2227 tr_TR
dc.identifier.endpage 2234 tr_TR


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster